Subsequent research has shown that while single-ingredient LABAs may be harmful, combination inhalers like Symbicort pose no ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

Based on our experience, COPD patients with asthma or the ACOS may benefit from a single inhaler combining ICS + LAMA + LABA, while recognizing that corticosteroid resistance may play a role in ...

SMART therapy refers to an asthma treatment approach known as single-maintenance ... One option is to start with an inhaled corticosteroid only before using a LABA-combination medication like ...

The FDA has requested five large clinical trials to evaluate fixed-dose ICS–LABA products with the primary outcome of life-threatening asthma exacerbation or death. The results will not be ...

a long-acting beta2-adrenergic agonist (LABA), delivered in a single once-daily dose in GSK’s Ellipta dry powder inhaler. Novartis says its results support recommendations put forward by the ...

The inhaler is not reusable. LABA as monotherapy (without ICS) for asthma can increase risk of asthma-related events. Do not initiate in rapidly deteriorating or potentially life-threatening ...

Patient feedback also indicated a preference for single-inhaler ... Breo Ellipta, a dual-therapy inhaler combining an ICS and LABA, was similarly found to provide comparable or incremental ...

Do not attempt to take the inhaler apart. Salmeterol is a selective LABA. The effects of beta 2 ... Exercise-Induced Bronchospasm (EIB) In 2 randomized, single-dose, crossover trials in ...

Patient feedback also indicated a preference for single-inhaler, once-daily treatments ... Breo Ellipta, a dual-therapy inhaler combining an ICS and LABA, was similarly found to provide comparable or ...